Auriclosene, formerly known as NVC-422 and CD07223, a potent and Broad spectrum antimicrobial agent. NVC-422 kills in vitro, all bacteria, viruses, yeasts and fungi against which they have been tested. NVC-422 is highly effective in in vitro studies against multi-drug resistant bacteria including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE). Auriclosene was demonstrated to be highly effective against well-established biofilm grown on urinary tract catheters. Auriclosene displays greater in vitro therapeutic index (ratio of toxicity to efficacy) than existing topical antiseptics. References: Rani SA, Celeri C, Najafi R, Bley K, Debabov D. Irrigation with N,N-dichloro-2,2-dimethyltaurine (NVC-422) in a citrate buffer maintains urinary catheter patency in vitro and prevents encrustation by Proteus mirabilis. Urolithiasis. 2015 Aug 18. [Epub ahead of print] PubMed PMID: 26282899.

纯度：≥98%

CAS：846056-87-9